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Abstract
Objective: To determine the efficacy of using pulmonary ultrasound as a diagnostic tool in acute
dyspnea of undetermined cause compared to the use of serum N-Terminal prohormone Brain
Natriuretic Peptide (NT-proBNP) in the diagnosis of heart failure.
Design: Systematic literature review
Methods: Searches were conducted in PubMed and Scopus using the terms pulmonary
ultrasound and congestive heart failure and studies within the last 10 years. Studies that used
pulmonary ultrasound compared to BNP as a marker for the diagnosis of heart failure were
included.
Results: All three studies found that the use of pulmonary ultrasound was a more specific
diagnostic aid for heart failure when compared with NT-proBNP.
Conclusion: The use of pulmonary ultrasound is highly specific in guiding the clinical diagnosis
of heart failure in patients presenting with acute dyspnea of an unknown cause.
Introduction
Heart failure affects 5.7 million adults in the United States.1 Once the diagnosis is made
half of the affected individuals will not live past five years. The disease also places a tremendous
economic burden on society, The Center for Disease Control estimates the annual cost of
hospitalizations for heart failure to be roughly 30.7 billion dollars.1 Common risk factors for
heart failure include obesity, diabetes and hypertension, all diseases that are on the rise,
potentially increasing the prevalence of the disease in the not so distant future.
A diagnosis of heart failure is currently made clinically, largely based on history and
physical exam. Due to the significant implications of the diagnosis, it is critical that heart failure
is diagnosed as quickly as possible in dyspneic patients presenting to the Emergency Department
Several imaging techniques and laboratory findings are currently being used to help the clinician
make the diagnosis of heart failure, but they are not without flaws. Chest radiographs are
commonly used to evaluate the lungs for several findings that are related to heart failure. These
include pleural effusions, interstitial edema, alveolar edema, pulmonary venous blood diversion
and a widened cardiothoracic ratio.2 These findings are not always present during acute heart
failure and the sensitivity of chest radiographs is not high enough to make a diagnosis.
A laboratory value popularly used in the diagnosis of CHF is the measure of N-Terminal
pro Brain Natriuretic Peptide (NT-proBNP). This biomarker is related to the stretch of the
ventricular myocytes and an elevated level demonstrates excessive ventricular work and stretch.2
There are a number of conditions that may be associated with ventricular stretching, including
acute coronary syndrome, pulmonary embolism, critical illness and old age, which makes this lab
value highly sensitive but not specific.3 NT-proBNP is able to reliably exclude heart failure in an
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acute setting with a high sensitivity, however it’s specificity remains variable and generally
requires confirmatory diagnosis.4
The use of pulmonary ultrasound has
been suggested as a tool to assist in making
the diagnosis of heart failure in the acute
setting. The examination can be easily
taught to clinicians and takes about a minute
to complete.5 Ultrasound is particularly
appealing as a diagnostic tool, as it is
readily available, non-invasive and
relatively inexpensive. It can be performed
by clinicians who are familiar with the
technology at the bedside making the
Figure 1. These arrows depict B lines on
findings available immediately for clinical
pulmonary ultrasound examination. 8
application.
Specifically, the presence of diffuse B
lines on pulmonary ultrasound is an excellent predictor of congestive heart failure. B lines are
hyperechoic vertical lines seen extending from the pleura to the bottom of the ultrasound screen,
and they represent thickened interstitium and fluid-filled alveoli.3 An example is included in
figure 1. Also referred to as comet tail artifacts or lung comets, B lines extend perpendicular to
the pleural line, radiating down as if in the shape of a comet’s tail.3
When utilizing pulmonary ultrasound to assess for pulmonary edema, the thorax is
divided into eight segments and assessed for B-lines in the lung. This technique is an established
protocol for lung ultrasound created by Cardinale, et al and Volpicelli et al.5,7 Using an eight
zone test, when all zones are positive, the
likelihood of CHF is largely increased.3 Each
thoracic zone is considered positive if three or
more B-lines are identified in each of the divided
zones. Subsequently, the ultrasound is considered
positive for pulmonary edema when two or more
of these B-line containing zones are adjacent to
each other.3 In summary, lung ultrasound is
positive for pulmonary edema when there are two
adjacent zones that contain three or more B lines
in each zone. A visual of the pulmonary zone is
Figure 2. The right anterior chest wall
included as figure 2. This indicates pulmonary
divided into 4 zones, PSL is the
congestion, a result of elevated ventricular pressures
parasternal line, AAL is the anterior
axillary line, PAL is the posterior axillary
causing pulmonary interstitial edema.4
line. Zones 5 through 8 are contralateral
The goal of this meta-analysis is to determine
equivalents.3
whether pulmonary ultrasound improves the
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specificity and accuracy of the diagnosis of congestive heart failure compared to NT-proBNP.
Due to the fact that NT-proBNP levels are increased in many non-CHF processes, it is not a
highly specific lab and therefore a test with increased specificity such as ultrasound is preferred.
A rapid and highly specific test such as ultrasound is invaluable at the bedside to rapidly
diagnose congestive heart failure so that proper treatment can be initiated. The studies included
in this meta-analysis compare these variables with a hope to improve their clinical utility and
effectively treat patients with acute undifferentiated dyspnea.
PICO
Population: Adults presenting to the Emergency Setting with acute dyspnea
Intervention: pulmonary ultrasound
Control: NT-proBNP
Outcome: Improved specificity and diagnostic accuracy of Congestive Heart Failure

Clinical Question: Does the use of pulmonary ultrasound improve specificity and therefore the
accuracy of the diagnosis of heart failure compared to the use of NT-proBNP (N-terminal
prohormone Brain Natriuretic
Peptide)?
Methods
In September of 2019,
a literature review search was
conducted and PubMed and
Scopus were utilized to
identify studies evaluating the
use of bedside pulmonary
ultrasound in comparison with
Brain Natriuretic Peptide
(BNP) for the diagnosis of
congestive heart failure. The
search terms “pulmonary
ultrasound” and “congestive
heart failure” were used.
Within PubMed, 297 articles
were identified based on these
search terms. Within Scopus,
33 articles were found based
on these keywords. We then
narrowed the search and
excluded 285 articles that
Figure 3. PRISMA Flow Diagram
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were from before the year 2010, not human subjects, not prospective cohort or randomized
control trials, or not related to congestive heart failure.
Following this elimination, 45 total articles which were then further narrowed down by
excluding trials that did not include patients presenting to the Emergency Department with acute
dyspnea as their chief complaint, and studies that did not specifically compare pulmonary
ultrasound to NT-proBNP for rapid diagnosis of congestive heart failure. The remaining 10
articles were narrowed down based on the strength of statistical studies and number of subjects
to 3 articles. An overview of the studies found in this review can be found in Table 1, and the
Prisma flow diagram can be referenced in Figure 3. The articles included in this literature review
assess the usefulness of point of care pulmonary ultrasound compared to BNP measurement in
the diagnosis of congestive heart failure in patients presenting with dyspnea to the Emergency
Setting.
Results
Table 1. Comparison of studies in the meta-analysis
Study 1: Pivetta et al

Study 2: Prosen et al

Study 3: Sartini et al

Year
Published

2019

2011

2017

Sample
Size

532

218

255

Journal

European Journal of
Heart Failure

Critical Care Journal

Internal and Emergency
Medicine

Study
Design

Randomized control
trial

Prospective cohort

Prospective blinded
observational

Duration of 14 months
Study

21 months

15 months

Efficacy
Outcomes

Accuracy of diagnosis
measured by
sensitivity, specificity,
PPV, NPV, +LR, - LR,
AUC

Accuracy of diagnosis
measured by sensitivity,
specificity, PPV, NPV,
+LR, -LR, AUC

Accuracy of diagnosis
measured by
sensitivity, specificity,
PPV, NPV, AUC
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Study 1- Lung Ultrasound integrated with clinical assessment for the diagnosis of acute
decompensated heart failure in the emergency department: a randomized controlled trial. Pivetta,
et al.9
Objective: The purpose of this study was to compare the diagnostic accuracy of lung ultrasound
versus chest x-ray and NT-proBNP measurements in the correct diagnosis of dyspneic patients
with congestive heart failure.
Study Design: This study was a randomized, multi-center trial performed in two Italian
academic hospitals, Scienza di Torino University Hospital in Turin, Italy and Careggi University
Hospital in Florence, Italy. The aim of the study was to compare the usefulness of clinical
examination plus lung ultrasound versus chest x-ray and NT-pro-BNP measurement in diagnosis
of acute decompensated heart failure (ADHF). The patient population were patients presenting to
the Emergency Department with acute dyspnea. A secondary outcome was assessing time for
evaluation for evaluation with pulmonary ultrasound compared to chest Xray and pro-BNP.
There were 532 patients, deemed eligible if they were over 18 years of age and presenting
with acute dyspnea defined as sudden onset of shortness of breath, not related to trauma. The
criteria are described in table 2. The median age of patients was 79 years old. Patients were then
randomized to be worked up as either the CXR (chest xray)/NT-proBNP group or the LUS
group. Lung ultrasound (LUS) was performed by a physician, with the presence of three or more
B lines in an intercostal space representing a positive area of increased lung density. The
presence of three or more B lines in two or more zones bilaterally was diagnosed as diffuse
interstitial syndrome. NT-proBNP levels were measured using a commercially available
immunoassay.
Following initial clinical examination, the physician was asked to indicate the presumed
cause of dyspnea as either ADHF (acute decompensated heart failure) or non-ADHF. CXR and
NT-proBNP were eventually performed on all patients, but these results were only made
available to the physician following their initial presumed diagnosis after LUS. Following
hospital discharge, two expert intensivists who were blinded to LUS results reviewed medical
records and confirmed ADHF based on the 2012 European Society of Cardiology guidelines for
heart failure. Time needed to reach diagnosis was also measured and compared in the two groups
studied (LUS and CXR/NT-proBNP).
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Table 2. Inclusion and Exclusion Criteria for Study 1
Study Design Pivetta, et al 2015
Inclusion Criteria

Exclusion Criteria

Patients presenting to the Emergency
Department with acute dyspnea >18 years
of age

Patients already mechanically ventilated with
positive pressure (invasively or non-invasively) at
time of first evaluation, or acute dyspnea in the
context of trauma

Study Results: Patients in the group where lung ultrasound was utilized integrated with clinical
assessment to diagnose ADHF showed higher sensitivity and specificity (93.4%, 95.2%) than
evaluation with CXR and NT-proBNP (85%, 88.7%). Diagnostic accuracy was also deemed
higher as demonstrated by an area under the receiver operating characteristic curve (AUC) of
0.95 compared to AUC of 0.87 with the CXR/ NT-proBNP approach. Results are organized in
table 3.
The clinical usefulness of each approach was assessed by evaluating net benefit using
decision curve analysis. Net benefit quantifies diagnostic gain by showing the benefit of a true
positive minus the harm of a false positive for ADHF. Net benefit calculations revealed that lung
ultrasound with clinical assessment would reduce diagnostic errors of ADHF by 7.98 cases per
100 patients. This was compared to CXR/NT-proBNP with clinical assessment which was shown
to reduce diagnostic errors by only 2.42 cases per 100 patients. Assessment with CXR/NTproBNP also results in higher false negative diagnoses and false positive diagnoses. Time needed
to formulate the diagnostic hypothesis of ADHF was also significantly reduced with LUS
approach.
Overall, the study shows that integration of lung ultrasound with clinical assessment is
more accurate and also offers more benefit than the current recommended diagnostic method of
clinical evaluation, CXR and NT-proBNP in patients in the ED presenting with acute dyspnea.
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Table 3. Results of Study 1; Pivetta et al 2015
Integrated Evaluation
Measurements

CXR/NT-proBNP (N=260) LUS (N=258)

Sensitivity

85% (95% CI 76.5–91.4%)

93.4% (95% CI 87.5–
97.1%),

Specificity

88.7% (95% CI 82.5–
93.3%)

95.2% (95% CI 89.8–
98.2%),

PPV

83.3% (95% CI 74.7–90%)

95% (95% CI 89.4–98.1%),

NPV

89.9% (95% CI 83.8–
94.2%)

93.7% (95% CI 87.9–
97.2%)

AUC

0.87 (p<0.01)

0.95 (p<0.01)

Study Critique: Some limitations in interpreting the results include the absence of standard
criteria to determine the final diagnosis of ADHF. This study utilized review of medical records
by two expert physicians/intensivists with another physician reviewing cases that were disagreed
upon. The study was unable to perform interobserver measurements for lung ultrasound
performed by different physicians. However, the authors state that LUS has been shown to have
high repeatability and reproducibility amongst performers even if they are inexperienced
sonographers. In another study performed by the same group, a high agreement was
demonstrated between both experienced and naïve lung ultrasound operators in both acquiring
and interpreting ultrasound images.
Overall, the study had a large patient study group with 532 patients, was a randomized
control trial, and was generalizable in terms of results. The patient population was diverse with
multiple comorbidities which is representative of most patients presenting to the Emergency
Department with ADHF. The ultrasound operators were of varying experience, which represents
the variety of clinicians in the Emergency Department who may be either expert or new to
sonography.

Study 2- Combination of lung ultrasound (a comet-tail sign) and N-terminal pro-brain natriuretic
peptide in differentiating acute heart failure from chronic obstructive pulmonary disease and
asthma as cause of acute dyspnea in prehospital emergency setting. Prosen, et al.
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Objective: To study the diagnostic accuracy of bedside lung ultrasound (presence of comet-tail
signs), NT-proBNP and clinical assessment in the differentiation of ADHF related dyspnea from
other pulmonary related dyspnea.
Study Design: This was a prospective cohort study performed at the Center for Emergency
Medicine in Maribor, Slovenia between July 2007 and April 2010. The primary aim of this study
was to determine the diagnostic accuracy in using the presence of bilateral B-lines on point of
care lung ultrasound compared to NT-proBNP in assessment of dyspneic patients in the prehospital setting.
The average age of the group of patients studied was 70.9 years old. There were 218
patients included in the study, who were deemed eligible if they presented with shortness of
breath as their primary complaint. Patients were excluded if they were age <18 years, had a
history of renal insufficiency, trauma, or currently were presenting with severe coronary
ischemia, pneumonia, pulmonary embolism, carcinoma, pneumothorax, pleural effusion, drug
intoxication, anaphylactic reaction, upper airway obstruction, bronchial stenosis or GERD.
Inclusion and exclusion criteria are listed in table 4.
Levels of NT-proBNP were measured using a portable Cardiac Reader device. Bedside
lung ultrasound was performed using a SonoSite portable ultrasound machine. Ten emergency
physicians performed ultrasound and identified the presence or absence of 3 or more B lines in
eight zones of the lungs. A positive result was deemed two or more positive zones bilaterally of
eight measured zones (this is per Cardinale et al and Volpicelli et al examination definitions). All
physicians who participated had attended a Critical Ultrasound provider course. Measurements
of NT-proBNP and ultrasound examinations were performed upon arrival to the emergency
department and before any medications were given.
It is the standard of care at this hospital to perform a bedside pulmonary ultrasound in
patients presenting with acute dyspnea. Physicians in the prehospital setting were blinded to the
results of NT-proBNP but knew the results of the ultrasound. The study also included internists
and cardiologists who were blinded to either ultrasound findings or NT-proBNP at the point of
admission or discharge respectively.
Table 4. Inclusion and Exclusion Criteria for Study 2
Study Design Prosen, et al 2011
Inclusion Criteria

Exclusion Criteria

Shortness of breath as primary
complaint (defined as sudden onset
of dyspnea without history of
chronic dyspnea or increase in
severity of chronic dyspnea)

Age <18 years, history of renal insufficiency, trauma,
severe coronary ischemia, pneumonia, pulmonary
embolism, carcinoma, pneumothorax, pleural effusion,
drug intoxication, anaphylactic reaction, upper airway
obstruction, bronchial stenosis and GERD
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Study Results: Ultrasound examination alone proved to be more accurate in the accurate
diagnosis of ADHF and was statistically significant. This was in comparison to both NT-proBNP
and clinical assessment alone with modified Boston criteria scoring. Lung ultrasound
examination had 100% sensitivity and 95% specificity in accurate diagnosis of ADHF, in
comparison to NT-proBNP with 92% sensitivity and 89% specificity. Comparison of the
methods was made using the x2 test with Bonferroni correction. Results are further explained in
table 5.
Ultrasound examination was found to have an odds ratio of 53.7 with a p value of <0.001
and 95% confidence interval for the presence of HT. This was in comparison to NT-proBNP
measurement with an odds ratio of 14.3 and p-value of <0.001. These results demonstrate that
ultrasound exam was found to be the strongest predictor of ADHF amongst ten significant
variables that were assessed including orthopnea, rales, and NT-proBNP measurement.
Table 5. Results of Study 2; Prosen et al 2011
Measurement NT-proBNP

Ultrasound examination

Sensitivity

92% (95% CI 88 to 95)

100% (95% CI 98 to 100)

Specificity

89% (95% CI 84 to 92)

95% (95% CI 91 to 100)

NPV

86% (95% CI 82 to 90)

100% (95% CI 98 to 100)

PPV

90% (95% CI 85 to 94)

96% (95% CI 93 to 100)

LR+

8.36 (95% CI 1.72 to 33.86) 20 (95% CI 1.98 to 89.94)

LR-

0.09 (95% CI 0.02 to 0.23)

0

AUROC

0.90 (95% CI 0.84 to 0.94)

0.94 (95% CI: 0.90 to 0.97)

OR

14.3 (95% CI 8.1 to 29.4)

53.7 (95% CI, 28.6 to 83.5)

Study Critique: One limitation of this study is that it was performed in a prehospital setting.
However, in Slovenia where it was performed, there are medical doctors on the ambulances who
performed the ultrasound and drew the serum markers for NT-proBNP so in essence it was a
similar setting to an emergency department.
10

The study demonstrated that ultrasound alone has higher sensitivity and specificity than
NT-proBNP alone and could be used as a diagnostic tool itself for accurate diagnosis of CHF.
The study also revealed that the combination of ultrasound with NT-proBNP has 100%
sensitivity, 100% specificity, 100% NPV and 100% PPV for differentiating heart failure
compared to other pulmonary causes in the prehospital setting. They suggest that if ultrasound
shows B lines, NT-proBNP should be measured following sonography to confirm the diagnosis.
There were five patients who had false positive results with ultrasound examination who
then went on to have NT-proBNP values of less than 1000 pg/mL and a history of COPD/
asthma. This suggests that in a small portion of patients, it is still necessary to confirm the
absence of ADHF with an NT-proBNP value. While in the majority of cases the study revealed
that ultrasound examination could be used alone, to achieve complete confidence in the diagnosis
of ADHF, measurement of NT-proBNP should be performed as well.
Overall, this study highlights the fact that pulmonary ultrasound can be utilized in the
prehospital setting for rapid identification of B lines indicating interstitial pulmonary edema and
therefore ADHF. This is vital information that can be relayed to the emergency department
physician upon arrival to the Emergency Department in order to initiate prompt and appropriate
treatment of ADHF.

Study 3: Which method is best for an early accurate diagnosis of acute heart failure?
Comparison between lung ultrasound, chest x-ray and NT pro-BNP performance: a prospective
study. Sartini, et al.
Objective: To compare and evaluate the performance of chest radiography, NT-proBNP and
lung ultrasound in identification of acute heart failure in patients presenting to the ED with
shortness of breath.
Study Design: This as a prospective observational study performed at the emergency department
of the University Hospital of Sienna from January 2011 to February 2013. The aim of this study
was to compare the accuracy in diagnosing heart failure to chest X-ray and NT-proBNP.
The average age of the patients was 79.98 years. There were 225 patients in this
study. Inclusion criteria for this study included patients over 18 years of age, presenting with
acute dyspnea (<24 hours) or worsening shortness of breath over a four day period not related to
trauma. Exclusion criteria for this study included age less than 18 years or dyspnea following
trauma. The criteria are available in table 6.
NT-proBNP was analyzed with ECLIA, Roche Methodics. The NT-proBNP level was
considered indicative of heart failure when greater than or equal to 300 pg/ml following the
European Society of Cardiology recommendations. Lung ultrasound was obtained upon initial
presentation to the emergency department within two hours. The Esaote MyLab30 and MyLab70
ultrasound machines were used with a variable-band convex array (3.5-5MHz). Six transverse
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scans of each hemithorax were performed. A positive region was defined by the presence of 3 or
more B-lines in transverse intercostal planes in two or more regions. The ultrasound was
performed by emergency room physicians who were blinded to the clinical data. Each physician
had previously performed at least 50 examinations supervised by an expert before starting the
study. The results were reviewed by an independent panel of experts made up of two
cardiologists and an emergency room physician who collected all of the data to determine the
final diagnosis.
Table 6. Inclusion and Exclusion Criteria for Study 3
Study Design, Sartini et al 2017
Inclusion Criteria

Exclusion Criteria

Age >18 years, presenting with acute dyspnea (sudden Age <18 years, dyspnea following
onset <24h) or worsening of shortness of breath over a trauma
4 day period not related to trauma

Study Results: The study found that lung ultrasound was more specific than NT-proBNP for
aiding in the diagnosis of heart failure. The study showed that the specificity of ultrasound is
greater than that of NT-proBNP. The sensitivity of lung ultrasound was 57.73% and specificity
was 87.97%. The sensitivity of NT-proBNP was 97.59% and the specificity of 27.56%. Results
are presented in table 7.
This study also reviewed the use of chest x-ray as the sole diagnostic method of heart
failure. Chest x-ray had a sensitivity of 74.49% and a specificity of 86.26%. The researchers also
compared the use of two diagnostic tools simultaneously and finally three diagnostic tools at a
time. These comparisons increased sensitivity and specificity as would be expected. Overall, the
study found that no test alone could be used to make the diagnosis of congestive heart failure.
However, the researchers did recommend a step-wise process that starts with chest x-ray and
lung ultrasound and a follow up measure of NT-proBNP if the diagnosis is still uncertain.
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Table 7. Results of Study 3; Sartini et al 2017
Measurement NT-proBNP

Ultrasound examination

Sensitivity

97.59 % (95 % CI 91.57–99.71) 57.73% (95 % CI 47.28–67.70)

Specificity

27.56 (95 % CI 20.01–36.19)

NPV

94.59 % (95 % CI 81.81–99.34) 74.05 % (95 % CI 66.49–80.69)

PPV

46.82 % (95 % CI 39.21–54.54) 77.78 % (95 % CI 66.4–86.73)

LR+

1.351 (95 % CI 20–1.51)

4.80 (95 % CI 2.94–7.83)

LR-

0.09 (95 % CI 0.02–0.35)

0.48 (95 % CI 0.38–0.61)

AUROC

75.5%

84%

87.97 % (95 % CI 81.20–92.96)

Study Critique: The study enrolled 42 patients who had previously received diuretic therapy in
the prehospital setting prior lung ultrasound, however, they also measured both sensitivity and
specificity in those who had not been treated. In the patients who had not been treated ultrasound
had a higher sensitivity and specificity when compared to the entire study population as would
be expected.
This study divided the hemithorax into 6 regions but found that studying only four
provided higher yield information. They based this finding on the dependent nature of pulmonary
edema. This is a limitation of the study as other studies used 8 quadrants to evaluate each
hemithorax. Cardinale et al and Volpicelli et al have set up defined quadrants and findings that
allow for a consistent pulmonary ultrasound evaluation. The lack of following these established
criteria is a limitation of this study.
The study also identified a small sample size of patients given the frequency of patients
with dyspnea presenting to the emergency room. They suggested enrolling more patients to
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improve the ability to generalize the findings. A larger sample size will improve any studies
ability to generalize findings and this is an area that could be improved in the study of pulmonary
ultrasound use and the diagnosis of heart failure.
Overall, this study did an excellent job of isolating the variables and blinding the
observers to other findings. It also showed that lung ultrasound can be accurately performed even
by providers with minimal training.
Discussion
Congestive heart failure is a growing cause of morbidity and mortality. As with all
medical maladies, making the diagnosis quickly and accurately is imperative for positive
outcomes. The diagnosis of heart failure is unique in that it is often made based on clinical
suspicion rather than a clearly defined laboratory test. In patients presenting to the emergency
department with acute dyspnea, a rapid and accurate diagnosis of heart failure can decrease the
time needed to treat patients which will in turn lead to improved long-term outcomes.
NT-proBNP has been used to improve the accuracy of a heart failure diagnosis but is
limited in its ability to accurately rule in CHF by a myriad of factors. Examples of artificially
high and low causes of BNP have been defined by Yoo, BS11 in table 8. While this biological
marker has utility, a more definitive test is needed. Ultrasound is a commonly used technology
that is easily adaptable to aid in the diagnosis of heart failure. With minimal additional training
the use of bedside ultrasound can provide a fast and reliable view of the lungs and be used to
enhance the clinical diagnosis of heart failure leading to faster treatment and improved outcomes.
The aim of our study was to compare the diagnostic utility of pulmonary ultrasound to NTproBNP in accurately reaching the diagnosis of heart failure.
Table 8. Factors Affecting BNP; Yoo, BS 2014
Factors that can account for high BNP levels and no CHF
- Age, Sex, Renal Failure, Myocardial Infarction, Acute large pulmonary embolism
Factors that can account for low BNP levels with CHF
- Obesity (BMI>30 kg/m2), Flash pulmonary edema, CHF secondary to causes upstream
from the left ventricle (Acute mitral regurgitation, Mitral stenosis), Stable NYHA class I
patients with low ejection fractions

All three studies showed that pulmonary ultrasound was a more specific diagnostic aid
than NT-proBNP. Ultrasound has the advantage of allowing an indirect visualization of the
thorax and potential pathology such as fluid accumulation. This is compared to the serum marker
NT-proBNP, which is only an indirect measure of the response to pathology. In all three studies
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NT-proBNP was found to have a lower specificity compared to the use of pulmonary ultrasound.
These findings are significant as they show that pulmonary ultrasound is an effective tool in
making the diagnosis of heart failure.
The limitations of this review include the setting ultrasound was performed. The aim was
to determine the use of pulmonary ultrasound in the emergency room in acute dyspneic patients
with an unclear diagnosis. Pivetta et al. and Sartini, et al. reflected this in their studies. However,
Prosen et al. performed their pulmonary ultrasound and serum markers in a prehospital setting,
while they still found ultrasound to be a better diagnostic aid, the prehospital environment and
the emergency room are unique settings which may limit the transferability of the results.
Another limitation identified is the procedure used during pulmonary ultrasound. A
standardized approach has been established but Sartini, et al. deviated from this technique
possibly altering the results of their study. It would be beneficial for future studies to utilize a
consistent pulmonary ultrasound technique such as created by Cardinale, et al and Volpicelli et
al. In this review, only one study was a randomized control trial (Pivetta et al), this may be seen
as a limitation. Additional randomized control trials would lend enhanced credibility to the use
of lung ultrasound in the diagnosis of heart failure.
To evaluate the overall utility of pulmonary ultrasound as a diagnostic test, likelihood
ratios were calculated for each study using sensitivity and specificity and compared in Table 9. A
positive likelihood ratio gives a quantifiable value to determine the likelihood that a disease state
is present given a positive result from the diagnostic test. In all of the studies in this review the
positive likelihood ratio of ultrasound was higher when compared to the positive likelihood ratio
of NT-proBNP. The positive likelihood ratios demonstrate the favorable use of pulmonary
ultrasound in making the diagnosis of heart failure compared to NT-proBNP.
Overall, this meta-analysis demonstrates that pulmonary ultrasound is a highly specific
test that can be used in practice in the assessment of patients presenting emergently with acute
dyspnea. The presence of three or more B-lines in two adjacent thoracic zones confers high
specificity for acute decompensated heart failure. Pulmonary ultrasound results in fewer false
positives than NT-proBNP and is therefore incredibly useful at the bedside to aid in the diagnosis
of CHF. The ramifications of this conclusion are that pulmonary ultrasound can and should be
used as a diagnostic aid in the initial assessment of patients with acute dyspnea.
Table 9. Positive Likelihood Ratios of BNP and LUS
Positive LR BNP

Positive LR LUS

Pivetta, et al9

7.5

19.5

Prosen, et al6

8.36

20

Sartini, et al10 1.35

4.80
15

Conclusion
These studies show that lung ultrasound is an effective tool compared to the serum
marker NT-proBNP in aiding in the diagnosis of heart failure. NT-proBNP has a lower
specificity and less utility in initial diagnosis. In regard to pulmonary ultrasound, each study
found that the presence of three or more B-lines in two adjacent thoracic zones confers a high
specificity to the diagnosis of heart failure. This demonstrates that lung ultrasound is an effective
tool for use in the assessment of the patient with acute dyspnea of undetermined cause. This
meta-analysis shows that pulmonary ultrasound should be used in patients presenting to the
emergency department with undifferentiated acute dyspnea before the use of NT-proBNP. If the
pulmonary ultrasound results are equivocal an NT-proBNP can be ordered to aid in diagnosis as
a second line diagnostic tool. This stepwise protocol prevents unnecessary lab orders with results
that may not yield useful information.
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